T cell costimulation and coinhibition: genetics and disease.

Lisa Scandiuzzi, Kaya Ghosh, Xingxing Zang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

T cell costimulatory and coinhibitory pathways are essential orchestrators and regulators of the adaptive immune response. In recent years, the costimulatory CD28 receptor and B7 ligand families have been expanded to include a total of four and seven members, respectively. Several polymorphisms, mutations, and deletions in both regulatory and protein-coding regions of these genes have subsequently been discovered and evaluated for genetic linkage to various human diseases. Here, we review this evidence as we discuss T cell costimulation and coinhibition in the context of genetic susceptibility to autoimmunity, cancer, and other diseases. As we gain further insight into the functional significance and mechanism of these immunoregulatory pathways by both genetic and immunological approaches, these receptors and ligands are poised to become key targets for immunotherapy.

Original languageEnglish (US)
Pages (from-to)119-128
Number of pages10
JournalDiscovery medicine
Volume12
Issue number63
StatePublished - Aug 2011
Externally publishedYes

Fingerprint

Inborn Genetic Diseases
Immunologic Receptors
Ligands
T-Lymphocytes
Genetic Linkage
Sequence Deletion
Adaptive Immunity
Genetic Predisposition to Disease
Autoimmunity
Immunotherapy
Open Reading Frames
Genes
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

T cell costimulation and coinhibition : genetics and disease. / Scandiuzzi, Lisa; Ghosh, Kaya; Zang, Xingxing.

In: Discovery medicine, Vol. 12, No. 63, 08.2011, p. 119-128.

Research output: Contribution to journalArticle

Scandiuzzi, L, Ghosh, K & Zang, X 2011, 'T cell costimulation and coinhibition: genetics and disease.', Discovery medicine, vol. 12, no. 63, pp. 119-128.
Scandiuzzi, Lisa ; Ghosh, Kaya ; Zang, Xingxing. / T cell costimulation and coinhibition : genetics and disease. In: Discovery medicine. 2011 ; Vol. 12, No. 63. pp. 119-128.
@article{4a2ec879616a475080daa413c0909af1,
title = "T cell costimulation and coinhibition: genetics and disease.",
abstract = "T cell costimulatory and coinhibitory pathways are essential orchestrators and regulators of the adaptive immune response. In recent years, the costimulatory CD28 receptor and B7 ligand families have been expanded to include a total of four and seven members, respectively. Several polymorphisms, mutations, and deletions in both regulatory and protein-coding regions of these genes have subsequently been discovered and evaluated for genetic linkage to various human diseases. Here, we review this evidence as we discuss T cell costimulation and coinhibition in the context of genetic susceptibility to autoimmunity, cancer, and other diseases. As we gain further insight into the functional significance and mechanism of these immunoregulatory pathways by both genetic and immunological approaches, these receptors and ligands are poised to become key targets for immunotherapy.",
author = "Lisa Scandiuzzi and Kaya Ghosh and Xingxing Zang",
year = "2011",
month = "8",
language = "English (US)",
volume = "12",
pages = "119--128",
journal = "Discovery medicine",
issn = "1539-6509",
publisher = "Discovery Medicine",
number = "63",

}

TY - JOUR

T1 - T cell costimulation and coinhibition

T2 - genetics and disease.

AU - Scandiuzzi, Lisa

AU - Ghosh, Kaya

AU - Zang, Xingxing

PY - 2011/8

Y1 - 2011/8

N2 - T cell costimulatory and coinhibitory pathways are essential orchestrators and regulators of the adaptive immune response. In recent years, the costimulatory CD28 receptor and B7 ligand families have been expanded to include a total of four and seven members, respectively. Several polymorphisms, mutations, and deletions in both regulatory and protein-coding regions of these genes have subsequently been discovered and evaluated for genetic linkage to various human diseases. Here, we review this evidence as we discuss T cell costimulation and coinhibition in the context of genetic susceptibility to autoimmunity, cancer, and other diseases. As we gain further insight into the functional significance and mechanism of these immunoregulatory pathways by both genetic and immunological approaches, these receptors and ligands are poised to become key targets for immunotherapy.

AB - T cell costimulatory and coinhibitory pathways are essential orchestrators and regulators of the adaptive immune response. In recent years, the costimulatory CD28 receptor and B7 ligand families have been expanded to include a total of four and seven members, respectively. Several polymorphisms, mutations, and deletions in both regulatory and protein-coding regions of these genes have subsequently been discovered and evaluated for genetic linkage to various human diseases. Here, we review this evidence as we discuss T cell costimulation and coinhibition in the context of genetic susceptibility to autoimmunity, cancer, and other diseases. As we gain further insight into the functional significance and mechanism of these immunoregulatory pathways by both genetic and immunological approaches, these receptors and ligands are poised to become key targets for immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84858607020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858607020&partnerID=8YFLogxK

M3 - Article

C2 - 21878189

AN - SCOPUS:84858607020

VL - 12

SP - 119

EP - 128

JO - Discovery medicine

JF - Discovery medicine

SN - 1539-6509

IS - 63

ER -